RELATIONSHIP BETWEEN THE VENOCONSTRICTOR ACTIVITY OF DIHYDROERGOTAMINE AND ITS PHARMACOKINETICS DURING ACUTE AND CHRONIC ORAL DOSING

被引：10

作者：

DEMAREES, H

WELZEL, D

DEMAREES, A

KLOTZ, U

TIEDJEN, KU

KNAUP, G

机构：

[1] SANDOZ AG,DEPT CLIN RES,NURNBERG,FED REP GER

[2] DR MARGARET FISCHER BOSCH INST CLIN PHARMACOL,STUTTGART,FED REP GER

[3] ST ELISABETH HOSP,DIV NUCL MED,BOCHUM,FED REP GER

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 30卷 / 06期

关键词：

D O I：

10.1007/BF00608216

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：685 / 689

页数：5

共 26 条

[1] INVESTIGATION OF THE VENOCONSTRICTOR EFFECT OF 8' HYDROXYDIHYDROERGOTAMINE, THE MAIN METABOLITE OF DIHYDROERGOTAMINE, IN MAN [J].

AELLIG, WH .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (02) :239-242

[2]

AELLIG WH, 1984, NEUESTER STAND DIHYD

[3]

Barbey K, 1965, Arch Klin Exp Dermatol, V222, P423, DOI 10.1007/BF00517262

[4] LOW ORAL BIOAVAILABILITY OF DIHYDROERGOTAMINE AND 1ST-PASS EXTRACTION IN PATIENTS WITH ORTHOSTATIC HYPOTENSION [J].

BOBIK, A ;

JENNINGS, G ;

SKEWS, H ;

ESLER, M ;

MCLEAN, A .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (05) :673-679

[5]

DEMAREES H, 1976, Z KARDIOL, V65, P478

[6]

DEMAREES H, 1970, DURCHBLUTUNGS STORUN, P248

[7]

DEMAREES H, 1977, MUNCHN MED WOCHENSCH, V40, P1301

[8]

JANSEN W, 1983, MUNCHEN MED WOCHEN, V125, P498

[9]

JENNINGS G, 1982, MED VECKOBULLETIN VE, V11

[10]

JUCHEMS R, 1968, Z KREISLAUFFORSCH, V57, P1198

← 1 2 3 →